Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (137)
- Compliance and enforcement (35)
- Import and export (35)
- Shortages and supply disruptions (17)
- Sunscreens (10)
- Advertising (7)
- COVID-19 (5)
- Labelling and packaging (5)
- Weight loss products (5)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1309 result(s) found, displaying 1076 to 1100
-
Safety alertsLipro Diet Pills pose a serious health risk and should not be taken. They contain sibutramine. This increases the risk of major cardiac events.
-
Safety alertsTGA safety alert on Poly Implant Prothèse (PIP) silicone gel breast implants outlines reports of implant rupture and international safety concerns, advising ongoing monitoring and consultation with healthcare professionals.
-
Safety alertsWe are updating safety information for Simvastatin due to new contraindications, precautions, and dosage recommendations. Consult your doctor if you have concerns.
-
Market actionsConcerns over the sterility of the affected lots were raised following the failure of the sterility testing conducted by the manufacturer.
-
Market actionsThe recall is being conducted because a routine sterility test on the Trident Catheter Valve in a particular set of lots has failed.
-
Market actionsSpecific lots of an additional contact lens model i.e. Avaira Sphere Contact Lens have been identified as being affected by the unintended presence of a residue identified as silicone oil.
-
Market actionsSpecific packs (lots) of Avaira Sphere contact lenses are being recalled by CooperVision Australia Pty Ltd.
-
Safety alertsThe TGA is advising that citalopram should no longer be used at doses greater than 40 mg per day. For some patients, the maximum recommended dose is now only 20 mg per day.
-
Safety alertsReduce Weight Fruta Planta capsules pose a serious health risk and should not be taken. They contain undeclared sibutramine and phenolphthalein. Both substances have serious safety concerns.
-
Market actionsThe manufacturer detected microbial contamination of the product after an overseas report of a visual abnormality of the product.
-
Market actionsWe are recalling all batches of Savacol Antiseptic Mouth & Throat Rinse (alcohol-free) due to bacterial contamination.
-
Safety alertsS-shape slim capsules pose a serious risk to your health and should not be taken. They contain undeclared sibutramine, fenfluramine, phenolphthalein, propranolol and nifedipine. This has serious safety concerns.
-
Safety alertsAdvice for health professionals and patients about the risk of increased blood pressure and heart rate with atomoxetine (Strattera), and new monitoring recommendations.
-
Market actionsXigris (drotrecogin alfa) is being withdrawn from the market because it does not improve survival rates in severe sepsis patients. Stop using it and consult your doctor for alternative treatments.
-
Market actionsThe product may have bacterial contamination and appear either runny or cloudy.
-
Market actionsA small number of Meducore Easy Automatic External Defibrillator (AEDs) are currently being recalled for product correction cannot be located.
-
Safety alertsTGA safety alert on topiramate highlights serious adverse events linked to its unapproved use for weight loss, including eye, kidney, and pregnancy‑related risks, and advises use only for approved indications.
-
Safety alertsThe TGA has become aware that the EIUS unicompartmental1 knee prosthesis supplied by Stryker Australia has a higher-than-expected revision rate (rate of revision surgery). Supply of the product in Australia has been suspended.
-
Safety alertsQing Tian Zhu tablets pose a serious health risk and should not be taken. They contain undeclared sildenafil, which may be harmful if taken without medical supervision.
-
Safety alertsBlack Ant capsules pose a serious health risk and should not be taken. The contain undeclared sildenafil and may be harmful if taken without medical supervision.
-
Market actionsAdditional devices have been identified as being affected by the 'Error 2' message.
-
Market actionsThis is an update to the alert issued by the TGA on 16 June 2011. Johnson and Johnson have advised the TGA of additional serial numbers affected by the recall.
-
Market actionsThis recall follows a recent increase in the number of failures of CI512 implant in the Cochlear Nucleus CI500 Implant range.
-
Market actionsRecall of un-implanted Cochlear Nucleus CI500 Implant Range.
-
Safety alertsMaxidus capsules pose a serious health risk and should not be taken. They contain undeclared sulfohydroxyhomosildenafil, which has serious safety concerns.